| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/11/2006 | EP1614758A2 Measuring lance for measuring operations and/or sampling in molten metals |
| 01/11/2006 | EP1614752A2 Novel human 7TM proteins and polynucleotides encoding the same |
| 01/11/2006 | EP1614744A1 Cell tissue culture management method and system |
| 01/11/2006 | EP1614694A1 Titanium dioxide complex having molecule distinguishability |
| 01/11/2006 | EP1614692A2 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 01/11/2006 | EP1614477A1 Method for separating substances using dielectrophoretic forces |
| 01/11/2006 | EP1614459A1 Positively charged membrane |
| 01/11/2006 | EP1614425A2 Leukotriene receptor antagonist |
| 01/11/2006 | EP1613983A2 Automatic fiber processing system including method and apparatus for producing end-aligned fiber samples |
| 01/11/2006 | EP1613968A1 A non-radioactive schilling test |
| 01/11/2006 | EP1613967A2 Methods for identifying therapeutic targets involved in glucose and lipid metabolism |
| 01/11/2006 | EP1613966A2 A method for detection of colorectal cancer in human samples |
| 01/11/2006 | EP1613965A2 Apparatus and method for detecting microscopic living organisms using bacteriophage |
| 01/11/2006 | EP1613964A2 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses |
| 01/11/2006 | EP1613963A2 Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 6(edg6) |
| 01/11/2006 | EP1613962A1 Reduction of migration shift assay interference |
| 01/11/2006 | EP1613961A2 Surface receptor complexes as biomarkers |
| 01/11/2006 | EP1613960A2 Methods of assessing crohn's disease patient phenotype by i2, ompc and asca serologic response |
| 01/11/2006 | EP1613959A2 Methods of detecting cancer cells in biological samples |
| 01/11/2006 | EP1613958A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 01/11/2006 | EP1613957A1 Method of analysing the cytoskeletal protein of cells |
| 01/11/2006 | EP1613956A2 Selective activation of cellular activities mediated through a common toll-like receptor |
| 01/11/2006 | EP1613955A1 Biosensor system |
| 01/11/2006 | EP1613954A1 Method of determining xenograft responses |
| 01/11/2006 | EP1613953A2 Anti-retroviral analysis by mass spectrometry |
| 01/11/2006 | EP1613951A1 Steroid hormone analysis by mass spectrometry |
| 01/11/2006 | EP1613947A1 Optical chemical sensing device with pyroelectric or piezoelectric transducer |
| 01/11/2006 | EP1613946A2 Self-contained assay device for rapid detection of biohazardous agents |
| 01/11/2006 | EP1613923A1 Method and apparatus for testing fibres |
| 01/11/2006 | EP1613891A1 Device for monitoring the flow of a fluid flowing through or from a conduit, such as a lubricant, and the monitoring method implemented by the device |
| 01/11/2006 | EP1613774A2 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof |
| 01/11/2006 | EP1613770A1 Markers for roscovitine |
| 01/11/2006 | EP1613767A1 Method of defining the differentiation grade of tumor |
| 01/11/2006 | EP1613765A1 A method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling |
| 01/11/2006 | EP1613750A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 01/11/2006 | EP1613749A2 Ligand-coupled initiator polymers and methods of use |
| 01/11/2006 | EP1613737A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/11/2006 | EP1613734A2 Visualizing expression data on chromosomal graphic schemes |
| 01/11/2006 | EP1613732A2 Intracellular complexes as biomarkers |
| 01/11/2006 | EP1613723A2 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 01/11/2006 | EP1613660A2 Compositions and methods relating to stop-1 |
| 01/11/2006 | EP1613659A1 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 01/11/2006 | EP1613655A1 Clostridium difficile focussed antibodies |
| 01/11/2006 | EP1613653A1 Secreted polypeptide species associated with cardiovascular disorders |
| 01/11/2006 | EP1613650A2 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/11/2006 | EP1613645A1 Analytical method and kit thereof |
| 01/11/2006 | EP1613642A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 01/11/2006 | EP1613554A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 01/11/2006 | EP1613434A1 Measuring froth stability |
| 01/11/2006 | EP1613420A2 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds |
| 01/11/2006 | EP1613341A2 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1613264A2 Gaucher disease drugs and methods of identifying same |
| 01/11/2006 | EP1613263A2 Monitoring and treatment of amyotrophic lateral sclerosis |
| 01/11/2006 | EP1613262A2 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 01/11/2006 | EP1613205A2 Erbb surface receptor complexes as biomarkers |
| 01/11/2006 | EP1613204A2 Assessing neuronal damage from blood samples |
| 01/11/2006 | EP1613159A2 Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-fungal agents |
| 01/11/2006 | EP1527090B1 Method of binding a compound to a surface |
| 01/11/2006 | EP1497464A4 Compositions and methods related to two-arm nucleic acid probes |
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | EP1461462A4 Pcr based high throughput polypeptide screening |
| 01/11/2006 | EP1451581A4 Toll-like receptor 3 signaling agonists and antagonists |
| 01/11/2006 | EP1444519A4 Method and apparatus for distinguishing crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to saccharomyces cerevisiae |
| 01/11/2006 | EP1399109A4 Separation of platelets from whole blood for use as a healant |
| 01/11/2006 | EP1330546B1 Method for the amplification and optional characterisation of nucleic acids |
| 01/11/2006 | EP1315972B1 Method for detecting the activity of active ingredients |
| 01/11/2006 | EP1252186B1 Use of neuregulin-beta as an indicator and/or target |
| 01/11/2006 | EP1240328B1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 01/11/2006 | EP1235925B1 Feeding assay for identifying nematicidal compounds |
| 01/11/2006 | EP1230552B1 Elisa for vegf |
| 01/11/2006 | EP1230545B1 Diagnostic testing kit for collection and testing of fluid samples with user configurable test strips and timer |
| 01/11/2006 | EP1179186B1 Method for identifying modulators of interacting proteins |
| 01/11/2006 | EP1135684B1 IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES |
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP1073476B1 Catheter for obtaining cellular material from breast ducts |
| 01/11/2006 | EP1027605B1 Method and kit for detecting cryptosporidium oocysts |
| 01/11/2006 | EP1023602B1 Protein-colloidal metal-aminodextran coated particle and methods of preparation and use |
| 01/11/2006 | EP1019545B1 Methods and reagents for preserving rna in cell and tissue samples |
| 01/11/2006 | EP1009768B1 Human persephin |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | EP0906573B1 Methods of diagnosing clinical subtypes of crohn's disease |
| 01/11/2006 | EP0868519B1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 01/11/2006 | EP0830450B1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/11/2006 | EP0731636B1 Cdn apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN2751308Y Aquatic breeding area ecological element monitoring device |
| 01/11/2006 | CN2751307Y Electrochemical biological detect test paper |
| 01/11/2006 | CN2751304Y Portable microfluid chip CCD imager |
| 01/11/2006 | CN1720539A Optical tomography of small objects using parallel ray illumination and post-specimen optical magnification |
| 01/11/2006 | CN1720456A Self-calibrated flow-through assay devices |
| 01/11/2006 | CN1720455A Reduction of the hook effect in membrane-based assay devices |
| 01/11/2006 | CN1720454A Method and device for transporting or binding-specific separation of electrically charged molecules |
| 01/11/2006 | CN1720453A Method of immobilizing polynucleotide on solid support, solid immobilization support thus obtained, method of detecting target polynucleotide from the solid support and solution for immobilizing polyn |
| 01/11/2006 | CN1720452A Method for screening modulators of mitochondrial fuctionning and new modulators obtained |
| 01/11/2006 | CN1720451A Method of analyzing coenzyme Q-10 and two-electron reduction product thereof and analysis system |
| 01/11/2006 | CN1720448A Analyzing device |
| 01/11/2006 | CN1720447A Analysis instrument |
| 01/11/2006 | CN1720443A Solid-state light source photolytic nitrogen dioxide converter |